Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Construction and Identification of a Cdna Library from Human Liver Tissues of Primary Liver Carcinoma

Construction of a Subtracted Cdna Library of Differentially Expressed Genes in Human Normal Liver Tissue and Primary Hepatocellular Carcinoma Tissue

Construction of a cDNA library of human hepatoma cells with apoptosis induced by adriamycin

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Construction and characterization of a cDNA library from human liver tissue of cirrhosis]

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Construction and Characterization of a Cdna Library from Human Liver Tissue with Chronic Hepatitis B

Primary Study of the Function of a Novel Gene BC047440 Highly Expressed in Human Hepatocellular Carcinoma

Construction of Human Liver Cancer Vascular Endothelium Cdna Expression Library and Screening of the Endothelium-Associated Antigen Genes

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

Construction and Screening of Suppression Subtractive Hybridization Library of Human Primary Hepatocellular Carcinoma

Construction and identification of human ovarian carcinoma cDNA phage expression library

Isolation of cDNA Clones Using PAC and BAC Probes

Identification of Candidate Diagnostic Tumor Markers for Human Hepatocellular Carcinoma Using Genechip Technology

Discovery and Analysis of Hepatocellular Carcinoma Genes Using Cdna Microarrays

Identification of Tumor-Associated Antigens in Human Hepatocellular Carcinoma by Autoantibodies.

Screening for serum binding proteins in subjects with primary hepatocellular carcinoma using a phage display system

Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.

Gene Expression Patterns in Human Liver Cancers

Identification of Characteristic TRB V Usage in HBV-associated HCC by Using Differential Expression Profiling Analysis.